“A Case Report Overwhelming Response to TNF-Alfa Inhibitor Infliximab “innovator” Vs. Adalimumab ‘Bio-similar’ in a Previously Therapy Naive Adult”. Indian Journal of Case Reports 8, no. 3 (March 27, 2022): 58–61. Accessed April 29, 2025. https://mansapublishers.com/index.php/ijcr/article/view/3317.